|
|
|
|
|
|
|
M T Wed Th F |
|
16 September, 2026 |
|
|
|
|
|
|
|
|
|
|
|
|
Trump's new pick to lead the FDA, Heidi Overton, is reportedly set to have her hearing before the Senate HELP Committee as soon as next week, ahead of the midterms. One topic that could come up: Overton was there when the president signed a controversial executive order unilaterally calling for a new childhood vaccine schedule and for the measles vaccine to be split into three separate shots.
The order, and the event, was a dismal display of inaccurate health information, with the president repeatedly suggesting the vaccine contributed to rising autism rates, despite years of evidence showing vaccines do not cause autism. Sen. Bill Cassidy (R-LA) called her role "almost disqualifying." |
|
|
|
Max Bayer |
Senior Reporter, Endpoints News
|
|
|
|
 |
|
Rep. John Moolenaar (R-MI) speaks at a Endpoints News event on China biotech in Washington, DC. (Credit: Alex Mills) |
|
|
|
by Max Bayer
|
WASHINGTON — Five large pharmaceutical companies have been cooperating with a congressional probe into clinical trials run at Chinese military hospitals, according to the House... | |
|
|
|
|
|
|
by Zachary Brennan
|
Yale and Harvard medical school faculty are questioning whether the FDA and American companies will actually benefit from the US-focused incentives in the next user... | |
|
|
|
|
|
|
|
|
by Andrew Dunn
|
Anthropic is deepening ties with the Danish drugmaker Novo, in the latest gain for the tech giant's life sciences business. In a Wednesday release... | |
|
|
|
|
|
|
by Kyle LaHucik
|
Novartis has scrapped development of a Phase 2 treatment candidate for amyotrophic lateral sclerosis, Endpoints News has learned. The Swiss pharma giant is ending work... | |
|
|
|
 |
|
|
|
by ENDPOINTS |
Plus news about VaxThera, Sironax, Circle Pharma, Nutshell Therapeutics, Evopoint and Sensorion. Gilead’s HIV PrEP pact in Latin America: The California drugmaker said it... | |
|
|
|
|
|
